Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Anemia (Sickle cell).php on line 2
Anemia (Sickle cell)
LE WE PMID CA
Anemia (Sickle cell)2535Anaemie (Sichelzellanaemie)

Anemia (Sickle cell)

Asthma (BASKET)

Autoantibodies Anti Annexin V

Cadasil

CNS (Stroke BASKET)

Fabry s disease

Hemoglobin F

Hemolysis

Histone deacetylase

Hydroxyurea Hydroxycarbamide

Kidney (Hyperfiltration)

Mitochondria (Mitochondriopathy)

Pulmonary hypertension

Thalassemia

2004  
1
Sickle cell disease; a general overview.
[15683091] Neth J Med 62(10): 364-74 (2004)
2010  
2
Definitions of the phenotypic manifestations of sickle cell disease.
[19902523] Am J Hematol 85(1): 6-13 (2010)
2009  
3
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.
[19610078] Am J Hematol 84(9): 618-25 (2009)
2005  
4
Bone marrow embolism in sickle cell disease: a review.
[15849760] Am J Hematol 79(1): 61-7 (2005)
2001  
5
Ethical issues in the management of sickle cell pain.
[11559953] Am J Hematol 68(2): 127-32 (2001)
2000  
6
Renal abnormalities in sickle cell disease.
[10706765] Am J Hematol 63(4): 205-11 (2000)
2005  
7
Ion transport pathology in the mechanism of sickle cell dehydration.
[15618480] Physiol Rev 85(1): 179-200 (2005)
1989  
8
Practical management of sickle cell disease.
[2696437] Arch Dis Child 64(12): 1748-51 (1989)
1991  
9
Vascular occlusion in sickle cell disease: current concepts and unanswered questions.
[2009364] Blood 77(7): 1405-14 (1991)
2006  
10
Current therapy of sickle cell disease.
[16434364] Haematologica 91(1): 7-10 (2006)
2004  
11
Established and experimental treatments for sickle cell disease.
[15020275] Haematologica 89(3): 348-56 (2004)
2008  
12
Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I.
[19074079] Hematology Am Soc Hematol Educ Program -(-): 186-92 (2008)
2008  
13
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
[19074078] Hematology Am Soc Hematol Educ Program -(-): 177-85 (2008)
2006  
14
Induction of fetal hemoglobin in the treatment of sickle cell disease.
[17124041] Hematology Am Soc Hematol Educ Program -(-): 58-62 (2006)
2006  
15
Prevention and management of stroke in sickle cell anemia.
[17124040] Hematology Am Soc Hematol Educ Program -(-): 54-7 (2006)
2006  
16
2005  
17
An evidence-based approach to the treatment of adults with sickle cell disease.
[16304360] Hematology Am Soc Hematol Educ Program -(-): 58-65 (2005)
2004  
18
2002  
19
Novel therapeutic approaches in sickle cell disease.
[12446417] Hematology Am Soc Hematol Educ Program -(-): 10-34 (2002)
1999  
20
2007  
21
Sickle cell disease: old discoveries, new concepts, and future promise.
[17404610] J Clin Invest 117(4): 850-8 (2007)
2002  
22
The initiation and progression of sickle cell nephropathy.
[12028473] Kidney Int 61(6): 2277-86 (2002)
2000  
23
Renal abnormalities in sickle cell disease.
[10620181] Kidney Int 57(1): 1-8 (2000)
2008  
24
The sickle cell crisis: a dilemma in pain relief.
[18315999] Mayo Clin Proc 83(3): 320-3 (2008)
2001  
25
1985  
26
Sickle cell nephropathy: new insights into its pathophysiology.
[3894760] Kidney Int 27(5): 711-7 (1985)
1989  
27
Diagnostic imaging of bone and joint abnormalities associated with sickle cell hemoglobinopathies.
[2655384] AJR Am J Roentgenol 152(6): 1153-9 (1989)
2007  
28
Musculoskeletal manifestations of sickle cell disease.
[17620464] Radiographics 27(4): 1005-21 (2007)
1998  
29
Sickle cell disease: imaging of cerebrovascular complications.
[9457180] Radiology 206(2): 311-21 (1998)
2010  
30
Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization.
[20658592] Am J Hematol 85(8): 611-3 (2010)
2011  
31
Asthma in sickle cell disease: implications for treatment.
[21490765] Anemia 2011(-): 740235 (2011)
2011  
32
Musculoskeletal manifestations of sickle cell anaemia: a pictorial review.
[21490766] Anemia 2011(-): 794283 (2011)
2003  
33
Managing sickle cell disease.
[14615343] BMJ 327(7424): 1151-5 (2003)
2005  
34
Genetics of cerebrovascular disorders.
[15667040] Mayo Clin Proc 80(1): 122-32 (2005)
2006  
35
Vasoocclusion in sickle cell anemia: are platelets really involved?
[16794229] Arterioscler Thromb Vasc Biol 26(7): 1415-6 (2006)
2011  
36
2010  
37
Genetic correction of sickle cell anemia and beta-thalassemia: progress and new perspective.
[20419277] ScientificWorldJournal 10(-): 644-54 (2010)
2008  
38
Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.
[19112541] ScientificWorldJournal 8(-): 1295-324 (2008)
2010  
39
How I use hydroxyurea to treat young patients with sickle cell anemia.
[20223921] Blood 115(26): 5300-11 (2010)
2009  
40
Sickle cell disease and stroke.
[19797523] Blood 114(25): 5117-25 (2009)
2007  
41
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.
[17429008] Blood 110(3): 1043-7 (2007)
2008  
42
Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void.
[17940207] Blood 111(3): 997-1003 (2008)
2011  
43
The rationale for using hydroxycarbamide in the treatment of sickle cell disease.
[21454878] Haematologica 96(4): 488-91 (2011)
2010  
44
Sickle cell disease: primum non nocere (first do no harm).
[20065076] Haematologica 95(1): 4-5 (2010)
2006  
45
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.
[16885048] Haematologica 91(8): 1076-83 (2006)
2010  
46
2007  
47
Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease.
[18024614] Hematology Am Soc Hematol Educ Program -(-): 84-90 (2007)
2007  
48
Hypercoagulability in sickle cell disease: new approaches to an old problem.
[18024615] Hematology Am Soc Hematol Educ Program -(-): 91-6 (2007)
2007  
49
Current issues in sickle cell pain and its management.
[18024616] Hematology Am Soc Hematol Educ Program -(-): 97-105 (2007)
2008  
50
Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia.
[18617435] Int J Biochem Cell Biol 40(11): 2341-7 (2008)
2003  
51
Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
[12826592] Am J Respir Crit Care Med 168(1): 3-4 (2003)
2007  
52
Sickle cell disease-associated pulmonary hypertension: a coat of many colors.
[17545455] Am J Respir Crit Care Med 175(12): 1218-9 (2007)
2009  
53
2007  
54
Sickle cell anemia-associated pulmonary arterial hypertension.
[18026658] J Bras Pneumol 33(5): 583-91 (2007)
2010  
55
Glomerular hyperfiltration in sickle cell disease.
[20299367] Clin J Am Soc Nephrol 5(5): 748-9 (2010)
2007  
56
Redox-dependent impairment of vascular function in sickle cell disease.
[17964418] Free Radic Biol Med 43(11): 1469-83 (2007)
2011  
57
Predictive value of anti-annexin V autoantibodies in the follow-up of vaso-occlusive crisis associated with sickle cell disease.
[21657843] Biomark Med 5(3): 363-4 (2011)
2008  
58
Hydroxyurea for the treatment of sickle cell disease.
[18457478] Evid Rep Technol Assess (Full Rep) -(165): 1-95 (2008)
2010  
59
Severe sickle cell disease--pathophysiology and therapy.
[19819341] Biol Blood Marrow Transplant 16(1 Suppl): S64-7 (2010)
2011  
60
Kidney abnormalities in sickle cell disease.
[21959727] Nefrologia 31(5): 591-601 (2011)
2009  
61
Hyperhemolysis syndrome in sickle cell disease.
[21083443] Expert Rev Hematol 2(2): 111-5 (2009)
2008  
62
NIH consensus development statement on hydroxyurea treatment for sickle cell disease.
[18309362] NIH Consens State Sci Statements 25(1): 1-30 (2008)
2011  
63
Splenic complications of sickle cell anemia and the role of splenectomy.
[22084706] ISRN Hematol 2011(-): 864257 (2011)
2007  
64
Pulmonary hypertension in sickle cell disease: relevance to children.
[17454785] Pediatr Hematol Oncol 24(3): 159-70 (2007)
2010  
65
A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
[20656451] J Pain Symptom Manage 40(3): 416-35 (2010)
PMC   
66
Cardiac autonomic dysfunction in sickle cell anaemia and its correlation with QT parameters.
[24665151] Niger Med J 54(6):382-5 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Anemia (Sickle cell).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Anemia (Sickle cell).php on line 92